Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer.
Crook J, Ludgate C, Malone S, Perry G, Eapen L, Bowen J, Robertson S, Lockwood G. Crook J, et al. Among authors: ludgate c. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):327-33. doi: 10.1016/j.ijrobp.2008.04.075. Epub 2008 Aug 15. Int J Radiat Oncol Biol Phys. 2009. PMID: 18707821 Clinical Trial.
Report of a multicenter Canadian phase III randomized trial of 3 months vs. 8 months neoadjuvant androgen deprivation before standard-dose radiotherapy for clinically localized prostate cancer.
Crook J, Ludgate C, Malone S, Lim J, Perry G, Eapen L, Bowen J, Robertson S, Lockwood G. Crook J, et al. Among authors: ludgate c. Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):15-23. doi: 10.1016/j.ijrobp.2004.02.022. Int J Radiat Oncol Biol Phys. 2004. PMID: 15337535 Clinical Trial.
Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- versus 8-month randomized trial.
Alexander A, Crook J, Jones S, Malone S, Bowen J, Truong P, Pai H, Ludgate C. Alexander A, et al. Among authors: ludgate c. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):23-30. doi: 10.1016/j.ijrobp.2009.01.030. Int J Radiat Oncol Biol Phys. 2010. PMID: 19395187 Clinical Trial.
Hemoglobin levels do not predict biochemical outcome for localized prostate cancer treated with neoadjuvant androgen-suppression therapy and external-beam radiotherapy.
Pai HH, Ludgate C, Pickles T, Paltiel C, Agranovich A, Berthelet E, Duncan G, Kim-Sing C, Kwan W, Lim J, Liu M, Tyldesley S. Pai HH, et al. Among authors: ludgate c. Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):990-8. doi: 10.1016/j.ijrobp.2006.02.008. Epub 2006 May 6. Int J Radiat Oncol Biol Phys. 2006. PMID: 16682135
Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer: clinical parameters.
Bruchovsky N, Klotz L, Crook J, Malone S, Ludgate C, Morris WJ, Gleave ME, Goldenberg SL. Bruchovsky N, et al. Among authors: ludgate c. Cancer. 2006 Jul 15;107(2):389-95. doi: 10.1002/cncr.21989. Cancer. 2006. PMID: 16783817 Free article. Clinical Trial.
Pion radiation for high grade astrocytoma: results of a randomized study.
Pickles T, Goodman GB, Rheaume DE, Duncan GG, Fryer CJ, Bhimji S, Ludgate C, Syndikus I, Graham P, Dimitrov M, Bowen J. Pickles T, et al. Among authors: ludgate c. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):491-7. doi: 10.1016/s0360-3016(96)00542-1. Int J Radiat Oncol Biol Phys. 1997. PMID: 9112443 Clinical Trial.
45 results